4//SEC Filing
O'NEIL PATRICK R. 4
Accession 0000874015-25-000240
CIK 0000874015other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:55 PM ET
Size
14.1 KB
Accession
0000874015-25-000240
Insider Transaction Report
Form 4
O'NEIL PATRICK R.
EVP CLO & General Counsel
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-30−14,827→ 30,203 totalExercise: $56.78From: 2022-01-04Exp: 2028-01-03→ Common Stock (14,827 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-29−10,473→ 45,030 totalExercise: $56.78From: 2022-01-04Exp: 2028-01-03→ Common Stock (10,473 underlying) - Sale
Common Stock
2025-09-30$64.68/sh−14,827$958,976→ 57,130 total - Sale
Common Stock
2025-09-29$64.54/sh−10,473$675,945→ 57,130 total - Exercise/Conversion
Common Stock
2025-09-30$56.78/sh+14,827$841,877→ 71,957 total - Exercise/Conversion
Common Stock
2025-09-29$56.78/sh+10,473$594,657→ 67,603 total
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.50 to $64.63 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.50 to $64.945 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001564926
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:55 PM ET
- Size
- 14.1 KB